238 related articles for article (PubMed ID: 1805045)
1. Flow cytometric DNA analysis of poorly differentiated adenocarcinoma of the colorectum.
Taniyama K; Suzuki H; Matsumoto M; Hakamada K; Toyama K; Tahara E
Jpn J Clin Oncol; 1991 Dec; 21(6):406-11. PubMed ID: 1805045
[TBL] [Abstract][Full Text] [Related]
2. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
[TBL] [Abstract][Full Text] [Related]
3. DNA quantitation by image analysis of paraffin-embedded colorectal adenocarcinomas and its prognostic value.
Bosari S; Lee AK; Wiley BD; Heatley GJ; Hamilton WM; Silverman ML
Mod Pathol; 1992 May; 5(3):324-8. PubMed ID: 1495937
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric analysis of DNA abnormalities in colorectal carcinomas.
Bocquillon PG; Daver A; Page M; Dalifard I; Chassevent A; Cellier P; Bertrand G; Larra F; George P; Chabrun B
Bull Cancer; 1989; 76(3):291-300. PubMed ID: 2736315
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
[TBL] [Abstract][Full Text] [Related]
6. Intratumor heterogeneity of K-ras2 mutations in colorectal adenocarcinomas: association with degree of DNA aneuploidy.
Giaretti W; Monaco R; Pujic N; Rapallo A; Nigro S; Geido E
Am J Pathol; 1996 Jul; 149(1):237-45. PubMed ID: 8686748
[TBL] [Abstract][Full Text] [Related]
7. Tumor DNA content in gallbladder carcinoma.
Sato Y; Tanaka J; Koyama K; van Gulik TM; Lygidakis NJ; van der Heyde MN
Hepatogastroenterology; 1993 Aug; 40(4):375-9. PubMed ID: 8406309
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma.
D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G
Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899
[TBL] [Abstract][Full Text] [Related]
9. [Dna ploidy in adenocarcinoma of Barrett's esophagus].
Flejou JF; Doublet B; Potet F; Metayer J; Hemet J
Ann Pathol; 1990; 10(3):161-5. PubMed ID: 2386598
[TBL] [Abstract][Full Text] [Related]
10. [Retrospective flow-cytometric analysis of the DNA content in colorectal carcinomas and the test of the prognostic significance of DNA ploidy].
Baretton G; Gille J; Oevermann E; Löhrs U
Verh Dtsch Ges Pathol; 1990; 74():233-7. PubMed ID: 1708591
[TBL] [Abstract][Full Text] [Related]
11. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
[TBL] [Abstract][Full Text] [Related]
13. DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.
Coleman RL; Schink JC; Miller DS; Bauer KD; August CZ; Rademaker AW; Lurain JR
Gynecol Oncol; 1993 Jul; 50(1):20-4. PubMed ID: 8349159
[TBL] [Abstract][Full Text] [Related]
14. Gastric cancer cell DNA content correlates with early and late results after gastrectomy.
Carlini M; Garofalo A; Rinaldi G; D'Agnano I; D'Angelo C; Zupi G; Vecchione A; Santoro E
Int Surg; 1994; 79(2):114-9. PubMed ID: 7928145
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
16. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer.
Beerman H; Smit VT; Kluin PM; Bonsing BA; Hermans J; Cornelisse CJ
Cytometry; 1991; 12(2):147-54. PubMed ID: 1646701
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic parameters and DNA analysis in colorectal adenocarcinomas.
Crissman JD; Zarbo RJ; Ma CK; Visscher DW
Pathol Annu; 1989; 24 Pt 2():103-47. PubMed ID: 2671879
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis in colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis].
Yamaguchi A; Ishida T; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1591-5. PubMed ID: 2263242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
